Mill Creek Life Sciences Overview

  • Founded
  • 2010
Founded
  • Status
  • Private
  • Latest Deal Type
  • Grant
  • Latest Deal Amount
  • $100K
Latest Deal Amount
  • Investors
  • 2

Mill Creek Life Sciences General Information

Description

Provider of cellular and biologic therapeutic services designed to offer human platelet lysate. The company's services engage in the production of cell culture supplement and involve in developing, licensing and commercializing intellectual property, patents and know-how related to the production of a cell culture supplement, enabling researchers to supplement cell culture used in stem cells and primary cells for clinical and research markets.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Biotechnology
Other Industries
Discovery Tools (Healthcare)
Primary Office
  • 221 1st Avenue South West
  • Suite 209
  • Rochester, MN 55902
  • United States
+1 (507) 000-0000
Want detailed data on 2M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Mill Creek Life Sciences Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
5. Grant 18-Jun-2019 $100K 00000 Completed Generating Revenue
4. Later Stage VC 07-Feb-2019 000 Cancelled Generating Revenue
3. Grant 18-Aug-2015 00.000 00000 Completed Generating Revenue
2. Early Stage VC 01-Jan-2013 $625K Completed Generating Revenue
1. Angel (individual) 14-Sep-2012 $625K $625K Completed Generating Revenue
To view Mill Creek Life Sciences’s complete valuation and funding history, request access »

Mill Creek Life Sciences Executive Team (3)

Name Title Board Seat Contact Info
William Mirsch Chief Executive Officer & Chairman
Steven Dietz Co-Founder, Board Member & Vice President
To view Mill Creek Life Sciences’s complete executive team members history, request access »

Mill Creek Life Sciences Board Members (6)

Name Representing Role Since
Allan Dietz Ph.D Mayo Clinic Ventures Board Member & Advisor 000 0000
Douglas Punke Mill Creek Life Sciences Board Member 000 0000
Franklyn Prendergast Self Board Member 000 0000
Janet Einspahr Self Board Member 000 0000
Steven Dietz Mill Creek Life Sciences Co-Founder, Board Member & Vice President 000 0000
You’re viewing 5 of 6 board members. Get the full list »

Mill Creek Life Sciences Investors (2)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
Regenerative Medicine Minnesota Government 000 0000 000000 0
Mayo Clinic Ventures Corporate Venture Capital Minority 000 0000 000000 0
To view Mill Creek Life Sciences’s complete investors history, request access »